bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 6, 2006, Pages

  Villanueva, Sandra ^a   Cespedes, Carlos ^a   Gonzalez, Alexis ^a   Vio, Carlos P ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Kidney; Morphogen; Regeneration

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; LIM PROTEIN; MORPHOGEN; NERVE CELL ADHESION MOLECULE; NOGGIN; OSTEOGENIC PROTEIN 1; PHOSPHOPROTEIN; PROTEIN ENGRAILED; PROTEIN HYPOXIA INDUCED FACTOR 1ALPHA; PROTEIN PHOSPHO SMAD; SMAD PROTEIN; TRANSCRIPTION FACTOR PAX2; VASCULOTROPIN; VIMENTIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; HYPOXEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BONE MORPHOGENETIC PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; KIDNEY FAILURE, ACUTE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; REPERFUSION INJURY;

EID: 33845441125     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00023.2006     Document Type: Article

References (66)

1. Abbate M, Brown D, and Bonventre J. Expression of NCAM recapitulates tubulogenic development in kidneys recovering from acute ischemia. Am J Physiol Renal Physiol 277: F454-F463, 1999.
2. Al-awqati Q and Oliver JA. Stem cells in the kidney. Kidney Int 61: 387-395, 2002.
3. Aviles R, Annex B, and Lederman R. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol 140: 637-646, 2003.
4. Bardella L and Comolli R. Differential expression of c-jun, c-fos and hsp 70 mRNAs after folic acid and ischemia-reperfusion injury: Effect of antioxidant treatment. Exp Nephrol 2: 158-165, 1994.
5. Basile DP, Donohoe D, Roethe K, and Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899, 2001.
6. Basile DP, Fredrich K, Alausa M, Vio CP, Liang M, Rieder MR, Greene AS, and Cowley Jr AW. Identification of persistently altered gene expression in kidney following functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 288: F253-F263, 2005.
7. Breier G, Albrecht U, Sterrer S, and Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532, 1992.
8. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, and Goligorsky MS. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282: F1140-F1149, 2002.
9. Brunet LJ, McMahon JA, McMahon AP, and Harland RM. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280: 1455-1457, 1998.
10. Cai Q, Dmitrieva N, Ferraris J, Brooks H, van Balkom B, and Burg M. Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance. Proc Natl Acad Sci USA 102: 503-508, 2005.
11. Chiba S, Kurokawa MS, Yoshikawa H, Ikeda R, Takeno M, Tadokoro M, Sekino H, Hashimoto T, and Suzuki N. Noggin and basic FGF were implicated in forebrain fate and caudal fate, respectively, of the neural tube-like structures emerging in mouse ES cell culture. Exp Brain Res 163: 86-99, 2005.
12. Dudley AT, Lyons KM, and Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9: 2795-2807, 1995.
13. Dudley AT, Godin RE, and Robertson EJ. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev 13: 1601-1613, 1999.
14. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, and Bonventre JV. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115: 1743-1755, 2005.
15. Esson ML and Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 137: 744-752, 2002.
16. Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, and Nah HD. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36: 254-266, 2005.
17. Freeburg PB and Abrahamson DR. Hypoxia-inducible factors and kidney vascular development. J Am Soc Nephrol 14: 2723-2730, 2003.
18. Goda N, Dozier SJ, and Johnson RS. HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal 5: 467-473, 2003.
19. Harlow E and Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1998.
20. Imgrund M, Grone E, Grone HJ, Kretzler M, Holzman L, Schlondorff D, and Rothenpieler UW. Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice. Kidney Int 56: 1423-1431, 1999.
21. Joannidis M, Cantley LG, Spokes K, Stuart-Tilley AK, Alper SL, and Epstein FH. Modulation of c-fos and egr-1 expression in the isolated perfused kidney by agents that alter tubular work. Kidney Int 52: 130-139, 1997.
22. Jones N, Voskas D, Master Z, Sarao R, Jones J, and Dumont DJ. Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO J 2: 438-445, 2001.
23. Karanova I, Dove L, Resau J, and Perantoni A. Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme. Development 122: 4159-4167, 1996.
24. Kim BS and Goligorsky MS. Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease. Korean J Intern Med 18: 65-75, 2003.
25. Kitamoto Y, Tokunaga H, and Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest 99: 2351-2357, 1997.
26. Khot S and Ghaskadbi S. FGF signaling is essential for the early events in the development of the chick nervous system and mesoderm. Int J Dev Biol 45: 877-885, 2001.
27. Kolatsi-Joannou M, Li XZ, Suda T, Yuan HT, and Woolf AS. Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros. Dev Dyn 222: 120-126, 2001.
28. Kopp JB. BMP receptors in kidney. Kidney Int 58: 2237-2238, 2000.
29. Lameire NH and Vanholder R. Pathophysiology of ischaemic acute renal failure. Best Pract Res Clin Anaesthesiol 18: 21-36, 2004.
30. Lazarous DF, Unger EF, Epstein SE, Stine A, Arevalo JL, Chew EY, and Quyyumi AA. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol 36: 1239-1244, 2000.
31. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, and Annex BH. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359: 2053-2058, 2002.
32. Lin F, Moran A, and Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115: 1756-1764, 2005.
33. Lutter G, Attmann T, Heilmann C, von Samson P, von Specht B, and Beyersdorf F. The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts. Eur J Cardiothorac Surg 22: 753-761, 2002.
34. Mayordomo R and Alvarez IS. Vertical regulation of En-2 expression and eye development by FGFs and BMPs. J Craniofac Genet Dev Biol 20: 64-75, 2000.
35. Mehta R. Outcomes research in acute renal failure. Semin Nephrol 23: 283-294, 2003.
36. Morrisey M, Hruska K, Guo G, Wang S, Chen Q, and Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13: S14-S21, 2002.
37. Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, and Wakitani S. Low-dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36: 399-407, 2005.
38. Nishida S, Nagamine H, Tanaka Y, and Watanabe G. Protective effect of basic fibroblast growth factor against myocyte death and arrhythmias in acute myocardial infarction in rats. Circ J 67: 334-339, 2003.
39. Oberbauer R, Schwarz C, Regele HM, Hansmann C, Meyer TW, and Mayer G. Regulation of renal tubular cell apoptosis and proliferation after ischemic injury to a solitary kidney. Lab Clin Med 138: 343-351, 2001.
40. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, and Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol 291: F176-F185, 2006.
41. Perantoni AO, Dove LF, and Karavanova I. Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci USA 92: 4696-4700, 1995.
42. Qi JP, Wu AP, Wang DS, Wang LF, Li SX, and Xu FL. Correlation between neuronal injury and caspase-3 after focal ischemia in human hippocampus. Chin Med J (Engl) 117: 1507-1512, 2004.
43. Rabie AB and Lu M. Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor during healing of allogeneic bone graft. Arch Oral Biol 49: 1025-1033, 2004.
44. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, and Eckardt KU. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13: 1721-1732, 2002.
45. Rothenpieler UW and Dressler GR. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development 119: 711-720, 1993.
46. Safirstein R. Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 4: 1387-1395, 1994.
47. Schrier RW, Wang W, Poole B, and Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14, 2004.
48. Singri N, Ahya SN, and Levin ML. Acute renal failure. JAMA 289: 747-751, 2003.
49. Sakurai H, Barros EJ, Tsukamoto T, Barasch J, and Nigam SK. An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors. Proc Natl Acad Sci USA 94: 6279-6284, 1997.
50. Stanley E, Biben C, Kotecha S, Fabri L, Tajbakhsh S, Wang CC, Hatzistavrou T, Roberts B, Drinkwater C, Lah M, Buckingham M, Hilton D, Nash A, Mohun T, and Harvey RP. DAN is a secreted glycoprotein related to Xenopus cerberus. Mech Dev 77: 173-184, 1998.
51. Stanton B and Koeppen B. The kidney. In: Physiology (5th ed.), edited by Berne R, Levi M, Koeppen B, and Stanton B. St. Louis, MO: Mosby, 2004.
52. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, and Neilson EG. Role of basic fibroblast growth factor-2 in epithelial mesenchymal transformation. Kidney Int 61: 1714-1728, 2002.
53. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, and Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63: 1714-1724, 2003.
54. Unger EF, Goncalves L, Epstein SE, Chew EY, Trapnell CB, Cannon 3rd RO, and Quyyumi AA. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol 85:1414 -1419, 2000.
55. Venkatachalam MA, Rennke HG, and Sandstrom DJ. The vascular basis for acute renal failure in the rat. Preglomerular and postglomerular vasoconstriction. Circ Res 38: 267-279, 1976.
56. Villanueva S, Glavic A, Ruiz P, and Mayor R. Posteriorization by FGF, Wnt and retinoic acid is required for neural crest induction. Dev Biol 241: 289-301, 2002.
57. Villanueva S, Cespedes C, and Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 290: R861-R870, 2006.
58. Vio CP, An SJ, Cespedes C, McGiff JC, and Ferreri NR. Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy. J Am Soc Nephrol 12: 649-658, 2001.
59. Vio CP, Cespedes C, Gallardo P, and Masferrer JL. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 30: 687-692, 1997.
60. Vio CP and Figueroa CD. Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Int 31: 1327-1334, 1987.
61. Vrljicak P, Myburgh D, Ryan AK, Van Rooijen MA, Mummery CL, and Gupta IR. Smad expression during kidney development. Am J Physiol Renal Physiol 286: F625-F633, 2004.
62. Wagner KD, Wagner N, Wellmann S, Schley G, Bondke A, Theres H, and Scholz H. Oxygen-regulated expression of the Wilms tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J 17: 1364-1366, 2003.
63. Witzgall R, Brown D, Schwarz C, and Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994.
64. Yoshida T, Kurella M, Beato F, Min H, Ingelfinger JR, Stears RL, Swinford RD, Gullans SR, and Tang SS. Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney Int 61: 1646-1654, 2002.
65. Zeisberg M, Shah AA, and Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibrosis and facilitates regeneration of injured kidneys. J Biol Chem 280: 8094-8100, 2005.
66. Zhang Q, Wang G, and Sun J. Pharmacokinetics of recombinant human basic fibroblast growth factor in rabbits and mice serum and rabbits aqueous humor. Acta Pharmacol Sin 25: 991-995, 2004.